You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aclacinomycins

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Taiyuan, Shanxi, China
    Tao Wang
Feb 9, 2023

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

Vasculopathy, Retinal, With Cerebral Leukodystrophy, Cerebroretinal Vasculopathy, Hereditary Trial in Saint Louis (aclarubicin)

Completed
  • Vasculopathy, Retinal, With Cerebral Leukodystrophy
  • Cerebroretinal Vasculopathy, Hereditary
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 17, 2020

Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)

Unknown status
  • Acute Myeloid Leukemia
  • Relapse Leukemia
  • Guangzhou, Guangdong, China
    Liang Wang
Aug 18, 2019

AML Trial in Beijing (Decitabine 20 mg/m²/day for 5 days)

Completed
  • AML
  • Decitabine 20 mg/m²/day for 5 days
  • Beijing, Beijing, China
    Navy General Hospital
Jun 6, 2019

Acute Myeloid Leukemia Trial in Changchun (Decitabine, Daunorubicin, Cytarabine, Mitoxantrone, Cytarabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Changchun, Jilin, China
    First Hospital of Jilin University
Jan 18, 2017

Acute Myeloid Leukemia Trial in Tianjin (CAG regimen (Aclacinomycin, cytarabine, with/w/o G-CSF), low dose cytarabine)

Unknown status
  • Acute Myeloid Leukemia
  • CAG regimen (Aclacinomycin, cytarabine, with/w/o G-CSF)
  • low dose cytarabine
  • Tianjin, Tianjin, China
    Treatment and Diagnosis Center of Leukemia
Oct 6, 2016